| Primary |
| Asthma |
50.0% |
| Status Asthmaticus |
50.0% |
|
| Blood Glucose Increased |
100.0% |
|
| Secondary |
| Rheumatoid Arthritis |
19.6% |
| Asthma |
16.1% |
| Product Used For Unknown Indication |
14.0% |
| Interstitial Lung Disease |
9.8% |
| Nervous System Disorder |
7.0% |
| Gastritis Prophylaxis |
4.9% |
| Hypertension |
4.9% |
| Hypercholesterolaemia |
4.2% |
| Lumbar Spinal Stenosis |
4.2% |
| Bronchitis |
2.1% |
| Epilepsy |
2.1% |
| Infantile Spasms |
2.1% |
| Bronchitis Chronic |
1.4% |
| Drug Use For Unknown Indication |
1.4% |
| Pneumonia |
1.4% |
| Productive Cough |
1.4% |
| Sputum Retention |
1.4% |
| Allergic Granulomatous Angiitis |
0.7% |
| Allergy Prophylaxis |
0.7% |
| Antiviral Treatment |
0.7% |
|
| Interstitial Lung Disease |
33.3% |
| Allergic Granulomatous Angiitis |
8.3% |
| Asthma |
8.3% |
| Leucine Aminopeptidase Increased |
8.3% |
| Rhabdomyolysis |
8.3% |
| Pneumonia |
4.2% |
| Pregnancy |
4.2% |
| Pyrexia |
4.2% |
| Status Epilepticus |
4.2% |
| Thirst |
4.2% |
| Thrombocytopenia |
4.2% |
| Ventricular Extrasystoles |
4.2% |
| Weight Decreased |
4.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.6% |
| Asthma |
20.4% |
| Rheumatoid Arthritis |
12.3% |
| Prophylaxis |
9.6% |
| Drug Use For Unknown Indication |
3.0% |
| Hypertension |
2.8% |
| Glycogen Storage Disease Type Ii |
2.5% |
| Premedication |
2.3% |
| Adverse Drug Reaction |
2.0% |
| Diabetes Mellitus |
2.0% |
| Myelodysplastic Syndrome |
2.0% |
| Antifungal Prophylaxis |
1.7% |
| Nasopharyngitis |
1.7% |
| Pruritus |
1.7% |
| Aplastic Anaemia |
1.3% |
| Emphysema |
1.3% |
| Schizophrenia |
1.3% |
| Anaemia |
1.2% |
| Bone Marrow Conditioning Regimen |
1.2% |
| Gastroenteritis |
1.2% |
|
| Asthma |
8.8% |
| Dyspnoea |
7.5% |
| Rheumatoid Arthritis |
7.5% |
| Thrombocytopenia |
7.5% |
| Tubulointerstitial Nephritis |
7.5% |
| White Blood Cell Count Increased |
7.5% |
| Anaphylactoid Reaction |
6.3% |
| Eosinophilic Pneumonia |
6.3% |
| Vomiting |
5.0% |
| White Blood Cell Count Decreased |
5.0% |
| Cardio-respiratory Arrest |
3.8% |
| Malignant Melanoma |
3.8% |
| Nausea |
3.8% |
| Rash |
3.8% |
| Restlessness |
3.8% |
| Cardiac Failure |
2.5% |
| Completed Suicide |
2.5% |
| Drug Dependence |
2.5% |
| Gait Disturbance |
2.5% |
| Heat Illness |
2.5% |
|
| Interacting |
|
| Serotonin Syndrome |
100.0% |
|
